Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Goldenwell Biotech, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
goldenwellbiotech.comAI Executive Summary
AI-powered analysis of 8-K filing content
Goldenwell Biotech dismissed its independent accounting firm Michael Gillespie & Associates on September 27, 2026, following a board recommendation. While prior audit reports contained no adverse opinions, this auditor change signals potential governance concerns and may indicate the company is seeking better alignment with its operational needs.
Key Takeaways
Goldenwell Biotech terminated its relationship with Michael Gillespie & Associates, PLLC as independent registered public accounting firm
The dismissal was approved by the board of directors on September 27, 2026
2 more takeaways
Filing Overview
What This Means
Goldenwell Biotech, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.